Introducing Citeline’s Sitetrove Diversity Module, Combining Robust Clinical Investigator and Site Intelligence with Patient Demographics to Support the Diversification of Clinical Trials
NEW YORK, May 23 (Korea Bizwire) — With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” Citeline’s new Sitetrove Diversity Module marries robust site and investigator intelligence with patient age, race and gender data, enabling data-driven decision making [...]